Click Here to Register »

2017 Lead Sponsor

INC Research

2017 Executive Sponsors

Mapi

2017 Associate Sponsors

Be the Partner
GlobalCare Clinical Trials
HealthiVibe
inVentiv Health Clinical
Langland
Raremark

2017 Supporting Sponsors

Patient Focused Medicines Development

2017 Supporting Partners

Biomed Central
CISCRP
EFPIA
ESPCH

2017 Media Partners

BioPharm Insight
CanBiotech
Labiotech_eu
MNT
Pharmalicensing
Pharmaphorum
Technology Networks

Day One

Making Patient Involvement a Standard Operating Procedure (SOP) in the Lifecycle of Medicines

Anton Hoos, MD, PhD, MBA

Head of Medical, Amgen Europe

Eric Low

Chief Executive, Myeloma UK

A 360° Perspective on Innovative Ways of Patient Involvement in Medicines Development

Industry Perspective

Anton Hoos, MD, PhD, MBA

Head of Medical, Amgen Europe

Regulatory Perspective

Isabelle Moulon

Senior Advisor on Stakeholders Engagement, EMA

EMA’s Methodology on Patient Engagement

Nathalie Bere, MSc

Patient Relations Coordinator, European Medicines Agency

Progress Report Discussion on the “Partnering with Patients in the Development and Lifecycle of Medicines: A Call for Action”

Nicholas Brooke

Chief Executive, PFMD

Jan Geissler

Director, European Patients’ Academy on Therapeutic Innovation (EUPATI)

Patient-focused Medicines’ Development to Inform Access Decisions

Anne Beal, MD

Chief Patient Officer, Sanofi

Eric Low

Chief Executive, Myeloma UK

Isabelle Moulon

Senior Advisor on Stakeholders Engagement, EMA

Victoria Thomas

Head of Public Involvement, Public Involvement Programme, National Institute for Health and Care Excellence (NICE)

Patients Influencing Policy

Alastair Kent

Director, Genetic Alliance UK

Shifting the Paradigm to What Matters the Most to Patients: Patient Centered Outcomes Beyond PRO’s

Anne Beal, MD

Chief Patient Officer, Sanofi

Aude Roborel de Climens, PhD

PRO Lead, Health Economics & Outcomes Research (HEOR), Sanofi

The GSK Health Advisory Board: Bringing Patient Insights into GSK Since 2004

Andrew Garvey

Global Patient Advocacy Lead, GlaxoSmithKline

Case Study: Advancing Patient-Centered Clinical Trials

Gail Adinamis

Founder and CEO, GlobalCare Clinical Trials

The Inspiring Hope Ideathon: Solutioning the Clinical Trial Awareness Gap

Christine Phillips

Senior Director, Site & Patient Access, INC Research

Patient Involvement Sources and Solutions

Pete Chan

Head of Research and Analysis, Raremark – Presentation

Melissa Harris

Senior Account Director, Langland – Presentation


Day Two

Panel Discussion: How Industry and Patients Can Work Collaboratively to Achieve Joint Goals in Medicines Development

Professor Andrew Miles, MSc, MPhil, PhD, DSc [hc]

SVP and Secretary General, European Society for Person Centered Healthcare

Panelists

Claire Bale

Head of Research Communications and Engagement, Parkinson’s UK

Sabine Bongardt

Global Lead, Lupus Policy and Advocacy, UCB

Tanja Keiper

Director, Global Clinical Operations, External Innovation, Merck

Pinal Patel

Strategic Recruitment Lead, Bristol-Myers Squibb

Richard Stephens

Patient / Consumer Lead, Chair Consumer Forum, National Cancer Research Institute

Oliver Timmis

CEO, AKU Society

Unlocking the Power of Patient Engagement within Clinical and Commercial

Duncan Arbour

Digital Strategy & Innovation for Healthcare, inVentiv Health Communications

Examining European Public & Patient Perceptions of Experiences with Clinical Trials

Ken Getz, MBA

Director of Sponsored Research / Founder, Tufts CSDD / CISCRP

Patients View on Why They Are/Are Not Participating in a Clinical Trial

Abbe Steel, MSc

Founder and CEO, HealthiVibe LLC

Patient Speakers:

Taelor Bennett

Patient and Advocate

Rosemary Najim

Patient, Co-chair and Patient Lead, Surrey Arrhythmia Support Group (Surrey ASG)

Barry Pinnington

Patient and Advocate

Christine Robinson

Patient and Advocate

Patient Centricity in Clinical Development: A Case Study on Key Learnings from Patient Advisory Board Meetings and New Ways to Bring Patient Centricity to the Next Level through Stakeholder Engagement

Tanja Keiper

Director, Global Clinical Operations, External Innovation, Merck

Case Study: Incorporating Patient Insights to Co-Create Solutions in R&D

Guy Yeoman

VP, Patient Centricity and Global Medical Affairs, AstraZeneca Europe

The PEN Initiative: BMS’ Patient Engagement Network & The Life of a Drug Through Approval

Pinal Patel

Strategic Recruitment Lead, Bristol-Myers Squibb

Considering Diverse Patient Needs in Clinical Trials

Kelly Franchetti, RN, CCRN, CEN

VP, Global Patient Insights and Engagement, Patient Centered Sciences, Mapi Group

Integrating Patient Needs Into a Shared Patient Community Beyond the Trial

Thomas Klein

Founder and CEO, Be the Partner

Advancing the Informed Consent Process for the Benefit of the Patient

Dr. med. Ingrid Klingmann, FFPM, FBCPM

Chairman, European Forum for Good Clinical Practice (EFGCP)

Sini Eskola, MSc

Director of Regulatory Affairs, European Federation of Pharmaceutical Industries and Association (EFPIA)

Marleen Kaatee

Training Graduate / Founder and President, EUPATI / PSC Patients Europe

How EUPATI Trains Patients to Put Them in the Position of Influence

Jan Geissler

Director, European Patients’ Academy on Therapeutic Innovation (EUPATI)